CLEVELAND, Nov. 29, 2010 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that Athersys is scheduled to present at the 22 nd Annual Piper Jaffray Health Care Conference to be held Tuesday, November 30, 2010 through Wednesday, December 1, 2010 at The New York Palace Hotel in New York City. Dr. Gil Van Bokkelen, Chairman and Chief Executive Officer, is scheduled to present on Tuesday, November 30, 2010 at 1:00 pm Eastern Standard Time.
A live audio webcast of the event may be accessed at Webcast URL: . A replay of the presentation will be available through Athersys' website at under the "Investor" Section and will remain available through Tuesday, December 14, 2010.
About Athersys
Athersys is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing MultiStem®, a patented, adult-derived "off-the-shelf" stem cell product platform for multiple disease indications, including damage caused by myocardial infarction, bone marrow transplantation and oncology treatment support, ischemic stroke, and inflammatory bowel disease. The Company is also developing a portfolio of other therapeutic programs, including orally active pharmaceutical product candidates for the treatment of metabolic and central nervous system disorders, utilizing proprietary technologies, including Random Activation of Gene Expression (RAGE®). Athersys has forged several key strategic alliances and collaborations with leading pharmaceutical and biotechnology companies, as well as world-renowned research institutions in the United States and Europe to further develop its platform and products. More information is available at .
The Athersys, Inc. logo is available at
CONTACT: Athersys, Inc. William (B.J.) Lehmann, J.D., President and COO (216) 431-9900 bjlehmann@athersys.com In-Site Communications Investor Relations: Lisa M. Wilson (917) 543-9932 lwilson@insitecony.com Pure Communications, Inc. Media Relations: Dan Budwick (973) 271-6085 dan@purecommunicationsinc.com
